Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017
Added 7 months ago Drug news
Urovant Sciences licenses vibegron from Merck Inc. and will initiate a Phase III trial in 2017 for overactive bladder treatment.
Roivant Sciences, announced the formation of Urovant Sciences, a new company focused on developing innovative therapies for urologic conditions. Urovant's...
Added 2 years ago Drug news
Phase III extension studies show advantages of Botox (onabotulinumtoxinA) in urinary incontinence- Allergan
Allergan has announced that results from an extension study of two phase III trials showed that long-term Botox (onabotulinumtoxinA) treatment...
Added 3 years ago Drug news
In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether Myrbetriq/Betmiga (mirabegron),...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A
Recommendations apply to men aged 40 years or older who seek professional help for various non-neurogenic benign forms of LUTS...
Added 1 year ago
Purpose: To investigate the association between overactive bladder (OAB) and coronary artery disease (CAD) as demonstrated on coronary angiography in patients > 65 years.
Added 3 days ago
Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.
Objectives: To compare the efficacy of onabotulinumtoxinA, mirabegron, and anticholinergics in adults with idiopathic overactive bladder (OAB) using network meta-analysis (NMA).
Added 7 days ago
Evaluate clinical aspects associated with the presence of nocturnal enuresis (NE) in children with a diagnosis of overactive bladder (OAB).
Added 1 year ago
- Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
- Credits available
- Registration required
- Subscription fee